Document Detail

The potential benefits of treatment of sleep apnea in heart failure.
MedLine Citation:
PMID:  18273493     Owner:  NLM     Status:  In-Data-Review    
At least half of patients with heart failure (HF) suffer from sleep apnea. Growing evidence suggests that there may be a strong pathophysiological link between chronic HF and sleep apnea due to nocturnal oxygen desaturation and sympathetic activation. It seems that sleep apnea contributes to systolic and diastolic HF, reduced left and right ventricular function, and arrhythmia (e.g. atrial fibrillation, bradycardia, or ventricular ectopy). Therefore, treatment of sleep apnea might alleviate cardiac symptoms and improve cardiac function. Nevertheless, the exact role of long-term treatment of sleep apnea in HF patients remains to be elucidated, as important clinical endpoints (e.g mortality) have been assessed in only a few studies. Heart Fail Monit 2008;5(4):106-11.
Stephan Steiner; Per O Schueller; Marcus G Hennersdorf; Bodo E Strauer
Related Documents :
9352833 - Correlation between anthropometric measurements of the oropharyngeal area and severity ...
14592253 - Scoring variability between polysomnography technologists in different sleep laboratories.
12112193 - Evaluation of sleep and driving performance in six patients with parkinson's disease re...
Publication Detail:
Type:  Journal Article     Date:  2008-02-01
Journal Detail:
Title:  Heart failure monitor     Volume:  5     ISSN:  1470-8590     ISO Abbreviation:  Heart Fail Monit     Publication Date:  2008  
Date Detail:
Created Date:  2008-02-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140283     Medline TA:  Heart Fail Monit     Country:  England    
Other Details:
Languages:  eng     Pagination:  106-11     Citation Subset:  IM    
Department of Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention.
Next Document:  State-of-the-Art Prevention of Heart Failure: Maladaptive versus Adaptive Hypertrophy.